Clinical Research
Opportunities

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Get Started
Group headshot of people

Clinical Research Opportunities

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Penn Medicine is conducting medical studies to develop new diagnostic and clinical treatments to improve current standards of care.

Recently Added/Updated trials

RE-AHFIRM

99 years or below
All genders
The primary purpose of this study is to evaluate the safety and efficacy of larsucosterol, as determined by transplant-free survival through Day 90 in participants with severe alcohol-associated hepatitis (AH) with pre-treatment Maddrey Discriminant Function (MDF) score greater than or equal to (>=) 32 and Model for End-stage Liver Disease (MELD) scores 21-30, inclusive.

LIFU for CUD

99 years or below
All genders
This is a feasibility study looking at Low Intensity Focused Ultrasound treatment to the ventral striatum in patients with cocaine use disorder.

ORKA 001-113 Open Label Extension (OLE)

99 years or below
All genders
This study is for adults with moderate-to-severe plaque psoriasis who have already participated in a previous Oruka Therapeutics study and choose to continue receiving ORKA-001 treatment. Participants may stay in the extension study for up to about 96 weeks and will then be followed for about 48 weeks after their last treatment visit.

IMPROVE-PAH

99 years or below
All genders
The goal of this study is to evaluate the efficacy and safety of IKT-001 treatment versus placebo in addition to background pulmonary arterial hypertension (PAH) therapy in adults with World Health Organization (WHO) Group 1 PAH. This is a 2-part randomized double blind placebo-controlled trial with a 24-week treatment period that consists of 6 outpatient visits, and the 24-week Extended DBPC.

CnF-DBS for Levodopa-Resistant FOG

99 years or below
All genders
This is a multi-site, prospective, randomized, sham-controlled, crossover, double-blinded feasibility clinical trial assessing the extent to which cuneiform nucleus deep brain stimulation (CnF DBS) can ameliorate freezing of gait (FOG) in Parkinsons Disease (PD) patients with severe, Levodopa-resistant gait freezing.

Volunteer Sign-Up

If you don’t see a trial that fits your needs, consider joining our research volunteer registry. By signing up, you’ll be notified if a study matches your background and health profile.

Healthy Volunteers

Clinical research studies currently seeking healthy individuals.

Virtual Studies

Also called Online or Decentralized studies. Some may be a mix of remote and in-person visits. 

Penn Medicine Logo Small

Penn Medicine experts answer questions from patient advocates and share groundbreaking medical developments happening at the University of Pennsylvania.

View More